questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
Oxidoreductases acting on CH-NH group donors
Oxidoreductases, (N-demethylating)
Oxidoreductases, (N-demethylating) : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Oxydoréductases
Déméthylation
Tests génétiques
Tests de métabolisme
Oxydoréductases
Enzymes
Réactions médicamenteuses
Dysfonctionnement enzymatique
Symptômes
Biomarqueurs
Oxydoréductases
Diagnostic
Tests sanguins
Métabolites
Diagnostic
Symptômes
5
Nausées
Réactions cutanées
Symptômes
Troubles neurologiques
Toxines
Symptômes
Effets secondaires
Médicaments
Déméthylation
Génétique
Environnement
Symptômes
Enfants
Troubles de l'attention
Symptômes
Prévention
5
Prévention
Médicaments
Déméthylation
Tests génétiques
Prévention
Risque
Éducation des patients
Médicaments
Prévention
Habitudes de vie
Fonction enzymatique
Prévention
Vaccinations
Infections
Prévention
Traitements
5
Traitements symptomatiques
Ajustements médicamenteux
Oxydoréductases
Suppléments
Antioxydants
Fonction enzymatique
Modifications alimentaires
Métabolisme
Oxydoréductases
Thérapie génique
Déficiences enzymatiques
Traitements
Médicaments
Effets indésirables
Ajustements
Complications
5
Complications
Réactions médicamenteuses
Dysfonctionnement
Complications
Traitement
Réversibilité
Qualité de vie
Complications
Symptômes chroniques
Surveillance
Ajustements de traitement
Prévention
Traitements
Complications
Allergies
Facteurs de risque
5
Facteurs de risque
Génétique
Environnement
Âge
Risque
Fonction enzymatique
Antécédents familiaux
Facteurs de risque
Troubles enzymatiques
Exposition
Toxines
Risque
Mode de vie
Complications
Prévention
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Oxidoreductases, (N-demethylating) : Questions médicales les plus fréquentes",
"headline": "Oxidoreductases, (N-demethylating) : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Oxidoreductases, (N-demethylating) : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-26",
"dateModified": "2025-04-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Oxidoreductases, (N-demethylating)"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases acting on CH-NH group donors",
"url": "https://questionsmedicales.fr/mesh/D000587",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases acting on CH-NH group donors",
"code": {
"@type": "MedicalCode",
"code": "D000587",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aminopyrine N-demethylase",
"alternateName": "Aminopyrine N-Demethylase",
"url": "https://questionsmedicales.fr/mesh/D000633",
"about": {
"@type": "MedicalCondition",
"name": "Aminopyrine N-demethylase",
"code": {
"@type": "MedicalCode",
"code": "D000633",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.276"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dihydropteridine reductase",
"alternateName": "Dihydropteridine Reductase",
"url": "https://questionsmedicales.fr/mesh/D004093",
"about": {
"@type": "MedicalCondition",
"name": "Dihydropteridine reductase",
"code": {
"@type": "MedicalCode",
"code": "D004093",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.361"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dimethylglycine dehydrogenase",
"alternateName": "Dimethylglycine Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050893",
"about": {
"@type": "MedicalCondition",
"name": "Dimethylglycine dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050893",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.369"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ethylmorphine-N-demethylase",
"alternateName": "Ethylmorphine-N-Demethylase",
"url": "https://questionsmedicales.fr/mesh/D005037",
"about": {
"@type": "MedicalCondition",
"name": "Ethylmorphine-N-demethylase",
"code": {
"@type": "MedicalCode",
"code": "D005037",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.400"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone Demethylases",
"alternateName": "Histone Demethylases",
"url": "https://questionsmedicales.fr/mesh/D056466",
"about": {
"@type": "MedicalCondition",
"name": "Histone Demethylases",
"code": {
"@type": "MedicalCode",
"code": "D056466",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.475"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sarcosine dehydrogenase",
"alternateName": "Sarcosine Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D050892",
"about": {
"@type": "MedicalCondition",
"name": "Sarcosine dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D050892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.662.582.550"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases, (N-demethylating)",
"alternateName": "Oxidoreductases, N-Demethylating",
"code": {
"@type": "MedicalCode",
"code": "D010089",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Christopher J Schofield",
"url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, UK."
}
},
{
"@type": "Person",
"name": "Rajeev Ramanan",
"url": "https://questionsmedicales.fr/author/Rajeev%20Ramanan",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Sodiq O Waheed",
"url": "https://questionsmedicales.fr/author/Sodiq%20O%20Waheed",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Christo Z Christov",
"url": "https://questionsmedicales.fr/author/Christo%20Z%20Christov",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA."
}
},
{
"@type": "Person",
"name": "Samuel E Ross",
"url": "https://questionsmedicales.fr/author/Samuel%20E%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Endometrial cancer after endometrial ablation: a systematic review.",
"datePublished": "2022-12-05",
"url": "https://questionsmedicales.fr/article/36375895",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-003866"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endometrial carcinosarcoma.",
"datePublished": "2023-02-06",
"url": "https://questionsmedicales.fr/article/36585027",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/ijgc-2022-004073"
}
},
{
"@type": "ScholarlyArticle",
"name": "Endometrial Hyperplasia.",
"datePublished": "2022-11-02",
"url": "https://questionsmedicales.fr/article/36357974",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/AOG.0000000000004989"
}
},
{
"@type": "ScholarlyArticle",
"name": "The relationship between endometrial thickening and endometrial lesions in postmenopausal women.",
"datePublished": "2022-08-25",
"url": "https://questionsmedicales.fr/article/36006486",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00404-022-06734-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Identification of Endometrial Cancer-Specific microRNA Biomarkers in Endometrial Fluid.",
"datePublished": "2023-05-12",
"url": "https://questionsmedicales.fr/article/37240034",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24108683"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxidoreductases acting on CH-NH group donors",
"item": "https://questionsmedicales.fr/mesh/D000587"
},
{
"@type": "ListItem",
"position": 6,
"name": "Oxidoreductases, (N-demethylating)",
"item": "https://questionsmedicales.fr/mesh/D010089"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Oxidoreductases, (N-demethylating) - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Oxidoreductases, (N-demethylating)",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Oxidoreductases, (N-demethylating)",
"description": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?\nQuels tests sont utilisés pour évaluer l'activité enzymatique ?\nQuels symptômes peuvent indiquer un dysfonctionnement enzymatique ?\nPeut-on utiliser des biomarqueurs pour le diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Endometrial+Neoplasms#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Oxidoreductases, (N-demethylating)",
"description": "Quels symptômes sont associés à une altération de la déméthylation ?\nLes troubles neurologiques peuvent-ils être liés à ces enzymes ?\nComment les effets secondaires des médicaments sont-ils liés ?\nLes symptômes varient-ils selon les individus ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Endometrial+Neoplasms#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Oxidoreductases, (N-demethylating)",
"description": "Comment prévenir les complications liées à la déméthylation ?\nY a-t-il des tests préventifs recommandés ?\nL'éducation des patients est-elle importante ?\nLes habitudes de vie peuvent-elles influencer la fonction enzymatique ?\nDes vaccinations peuvent-elles aider à prévenir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Endometrial+Neoplasms#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Oxidoreductases, (N-demethylating)",
"description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nPeut-on utiliser des suppléments pour améliorer la fonction enzymatique ?\nLes modifications alimentaires peuvent-elles aider ?\nDes thérapies géniques sont-elles envisageables ?\nLes médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Endometrial+Neoplasms#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Oxidoreductases, (N-demethylating)",
"description": "Quelles complications peuvent survenir en cas de dysfonctionnement ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles être prévenues ?\nY a-t-il des complications spécifiques aux traitements ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Endometrial+Neoplasms#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Oxidoreductases, (N-demethylating)",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge joue-t-il un rôle dans le risque de dysfonctionnement ?\nLes antécédents familiaux sont-ils un facteur de risque ?\nL'exposition à des toxines peut-elle augmenter le risque ?\nLe mode de vie influence-t-il le risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D010089?mesh_terms=Endometrial+Neoplasms#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en oxydoréductases N-déméthylantes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'activité enzymatique ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de métabolisme des médicaments et des dosages enzymatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un dysfonctionnement enzymatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes tels que des réactions médicamenteuses inattendues peuvent survenir."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des biomarqueurs pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains biomarqueurs peuvent indiquer une activité enzymatique altérée."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent mesurer les niveaux de métabolites spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une altération de la déméthylation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, des vomissements et des réactions cutanées peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques peuvent-ils être liés à ces enzymes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en raison d'une accumulation de toxines."
}
},
{
"@type": "Question",
"name": "Comment les effets secondaires des médicaments sont-ils liés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une déméthylation inefficace peut entraîner des effets secondaires imprévus."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon les individus ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la génétique et de l'environnement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus aigus, comme des troubles de l'attention."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées à la déméthylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les médicaments connus pour interférer avec la déméthylation peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests préventifs recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques peuvent être recommandés pour les personnes à risque."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les médicaments et leurs effets est crucial."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie peuvent-elles influencer la fonction enzymatique ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des habitudes de vie saines peuvent améliorer la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Des vaccinations peuvent-elles aider à prévenir des complications ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui compliquent les traitements."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements symptomatiques et des ajustements médicamenteux peuvent être nécessaires."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des suppléments pour améliorer la fonction enzymatique ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments comme les antioxydants peuvent aider à soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les modifications alimentaires peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut soutenir le métabolisme et la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Des thérapies géniques sont-elles envisageables ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est une option potentielle pour corriger des déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être ajustés pour éviter des effets indésirables ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ajuster les doses ou changer de médicament peut réduire les effets indésirables."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir en cas de dysfonctionnement ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des réactions médicamenteuses graves peuvent se produire."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en provoquant des symptômes chroniques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une surveillance régulière et des ajustements de traitement peuvent prévenir les complications."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications spécifiques aux traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains traitements peuvent entraîner des complications spécifiques, comme des allergies."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des facteurs génétiques, environnementaux et liés au mode de vie peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque de dysfonctionnement ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque peut augmenter avec l'âge en raison de la diminution de la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles enzymatiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines peut-elle augmenter le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines environnementales peut affecter la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque de complications ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque de complications liées à la déméthylation."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford, UK.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA.
Present address: Department of Chemistry, National Institute of Technology, Rourkela, Odisha, 769001, India.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Michigan Technological University, Houghton, Michigan, 49931, USA.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, Australia.
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 22, Australia.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Genomics and Epigenetics Division, Garvan Institute of Medical Research, Sydney, Australia.
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney 22, Australia.
Centro Andaluz de Biología del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andalucía, Seville, Spain.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India. baishnabtripathy@yahoo.com.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
2 publications dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic and Specialty Medicine-DIMES, Alma Mater Studiorum, University of Bologna, Via San Giacomo 14, 40126 Bologna, Italy.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Cancer Centre, Faculty of Health Sciences, University of Macau, Taipa, China. Electronic address: echeung@um.edu.mo.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Department of Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China; Shenzhen Key Laboratory of Gene Regulation and Systems Biology, School of Life Sciences, Southern University of Science and Technology, Shenzhen, China. Electronic address: andrewh@sustech.edu.cn.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
1 publication dans cette catégorie
Affiliations :
Jiangsu Key Laboratory of TCM Evaluation and Translational Research School of Traditional Chinese Pharmacy China Pharmaceutical University Nanjing Jiangsu P. R. China.
Publications dans "Oxidoreductases, (N-demethylating)" :
To investigate whether a previously performed endometrial ablation is associated with the development and diagnosis of endometrial cancer....
First, a systematic review was performed of the articles reporting the incidence of endometrial cancer in patients treated with endometrial ablation. Second, a systematic review was performed to ident...
Based on 11 included studies, the incidence of endometrial cancer in a population of 29 102 patients with a prior endometrial ablation ranged from 0.0% to 1.6%.A total of 38 cases of endometrial cance...
Previous endometrial ablation is not associated with the development of endometrial cancer. Diagnostic work-up is not impeded by previous endometrial ablation. In addition, endometrial cancers after e...
Endometrial carcinosarcoma is a rare and aggressive high-grade endometrial carcinoma with secondary sarcomatous trans-differentiation (conversion theory). The clinical presentation and diagnostic work...
The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the etiology and risk factors, histologic classification and subtypes, malignant progression risks, prevention op...
The study aims to investigate the relationship between endometrial thickening and endometrial lesions in postmenopausal women....
Totally 390 postmenopausal patients with endometrial thickening ≥ 5 mm were enrolled from June 2016 to April 2020, among whom 188 patients were asymptomatic and 202 patients were symptomatic....
There were 50 cases with endometrial cancer and precancerous lesions and 150 cases with benign lesions in the symptomatic group, significantly higher than that in the asymptomatic group. The most comm...
The incidence of endometrial cancer and precancerous lesions in postmenopausal women with endometrial thickening and vaginal bleeding is higher than that of asymptomatic women. The endometrial thicken...
Abnormal uterine bleeding is a common benign gynecological complaint and is also the most common symptom of endometrial cancer (EC). Although many microRNAs have been reported in endometrial carcinoma...
The risk of developing endometrial hyperplasia after diagnosis of endometriosis has not been determined. Moreover, the risk of endometrial cancer associated with endometriosis is unclear. This nationw...
This population-based observational study analyzed data from the Korean National Health Insurance (NHI) database, including 147,869 women who were diagnosed with endometriosis from 2002 to 2017, with ...
Among three million women in this population, 16,377 women were diagnosed with endometrial hyperplasia, and 1795 women were diagnosed with endometrial cancer over 19,931,794 person-years of follow-up....
The risks of endometrial hyperplasia and endometrial cancer were found to be significantly higher in women with than without endometriosis. The presence of endometriosis did not affect overall surviva...
To investigate the factors related to endometrial cancer (EC) in postmenopausal women with endometrial thickening and the value of endometrial thickness (ET) in predicting EC....
A retrospective study of 385 referrals to our department for hysteroscopic diagnostic curettage assessment was carried out. Univariate analysis and multiple logistic regression analysis were used to i...
The follow-up period from the identification of endometrial thickening to pathological confirmation of EC was from 2 weeks to 3 months. In the postmenopausal bleeding (PMB) group, a total of 47 partic...
For postmenopausal women with increased ET and PMB, older age, thicker ET, and polypoid mass-like lesions on transvaginal ultrasound were independent associated factors for EC. An ET greater than 9.5 ...
Endometrial cancer is the most common gynecologic cancer in the United States and Europe, with an increasing incidence rate in high-income countries. MR imaging is recommended for treatment planning b...
The Cancer Genome Atlas (TCGA) endometrial cancer data expanded our knowledge about the role of different immunotherapeutic approaches based on molecular subtypes. Immune checkpoint inhibitors demonst...
To evaluate whether the amount of preoperative endometrial tissue surface is related to the degree of concordance with final low- and high-grade endometrial cancer (EC). In addition, to determine whet...
A retrospective cohort study within the European Network for Individualized Treatment of Endometrial Cancer (ENITEC). Surface of preoperative endometrial tissue samples was digitally calculated using ...
The study cohort included 573 tumor samples. Overall concordance between pre- and postoperative diagnosis was 60.0%, and 88.8% when classified into low- and high-grade EC. Upgrading (preoperative low-...
The amount of preoperative endometrial tissue surface was inversely related to the degree of concordance with final tumor low- and high-grade. Obtaining higher amount of preoperative endometrial tissu...